Comparison among Different Scoring Systems in Predicting Procedural Success and Long-Term Outcomes after Percutaneous

Artis Kalnins1, Ieva Strele2, Aivars Lejnieks3,4

  • 1Clinic of Cardiovascular diseases, Riga East University Hospital, Riga, LV 1038, Latvia. artis.kalnins@aslimnica.lv.

Insights

Four scoring systems moderately predict procedural success in chronic total coronary artery occlusions (CTO) percutaneous coronary intervention (PCI). PROGRESS CTO and CASTLE scores identify patients with worse long-term survival after successful PCI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Technology Assessment

Background:

  • Chronic total coronary artery occlusions (CTO) require complex percutaneous coronary intervention (PCI).
  • Various scoring systems exist to predict PCI success, but their comparative performance and impact on long-term outcomes are not well-established.
  • Accurate risk stratification is crucial for managing CTO patients.

Purpose of the Study:

  • To evaluate the predictive ability of four CTO scoring systems (J CTO, PROGRESS CTO, CL, and CASTLE) for procedural success in PCI.
  • To assess the association of these scores with long-term all-cause mortality after successful CTO PCI.

Main Methods:

  • Retrospective analysis of 551 patients undergoing elective CTO PCI from 2007-2016.
  • Calculation and comparison of J CTO, PROGRESS CTO, CL, and CASTLE scores.
  • Receiver operating characteristic (ROC) curve analysis for procedural success prediction.
  • Kaplan-Meier and Cox regression analyses for long-term survival assessment.

Main Results:

  • Procedural success was achieved in 454 out of 551 cases.
  • All scoring systems demonstrated a significant inverse correlation between complexity score and procedural success (p < 0.001).
  • The J CTO score showed the highest predictive accuracy for procedural success (AUC = 0.714).
  • During a median 6.8-year follow-up, the PROGRESS CTO and CASTLE scores were significantly associated with increased all-cause mortality risk in patients with successful PCI.
  • High PROGRESS CTO scores (HR 1.81) and high/intermediate CASTLE scores (HR 3.68/2.15) predicted significantly higher mortality risk.

Conclusions:

  • All evaluated CTO scoring systems offer moderate predictive capability for procedural success.
  • The PROGRESS CTO and CASTLE scoring systems are valuable for identifying CTO patients at higher risk of long-term mortality following successful PCI.
  • J CTO and CL scores did not demonstrate an association with long-term survival outcomes.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
903
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
380
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
218
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
332
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
596
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
6.7K